Indeed, it has previously been reported that p300-dependent histone acetylation can recruit β-catenin to enhancers during stem cell differentiation (53) and, conversely, that β-catenin can recruit p300/CBP to target genes in colon cancer cells and Xenopus embryos (54, 55). This evidence concerns the gene EP300 and malignant colon neoplasm.